Gut microbiota in esophageal cancer: mechanisms, clinical implications, and therapeutic potential. [PDF]
Li Y +8 more
europepmc +1 more source
Gut microbiota-mediated chemotherapy resistance in colorectal cancer: mechanisms and precision interventions. [PDF]
Li Y, Wang F, Li T, Liu Y.
europepmc +1 more source
Epidemiology and Clinical Profiles of <i>Bacteroides fragilis</i> Bacteremia in a Tertiary Care Setting: A 5-Year Review. [PDF]
Sönmezer MÇ +6 more
europepmc +1 more source
The role of human microbiota in breast cancer pathogenesis and treatment. [PDF]
Qiu J +9 more
europepmc +1 more source
Distinct prophage infections in colorectal cancer-associated Bacteroides fragilis. [PDF]
Damgaard F +8 more
europepmc +1 more source
Bacteriophage-mediated restoration of epithelial integrity, DNA damage response, and transcriptomic homeostasis in colon organoids exposed to ETBF and pks + E. coli. [PDF]
Song MH +9 more
europepmc +1 more source
An electron transport complex required in the gut sensitizes <i>Bacteroides</i> to a pore-forming type VI secretion toxin. [PDF]
Ratner HK +9 more
europepmc +1 more source
An anaerobic pathogen rewires host metabolism to fuel oxidative growth in the inflamed gut. [PDF]
Spiga L +27 more
europepmc +1 more source
Microbiomics: Novel Biomarkers of Colorectal Cancer Diagnosis and Prognosis. [PDF]
Yang L, Meng W, Yang T, Zhu Y, Wang Z.
europepmc +1 more source
Repurposing Drugs as Bacteroides fragilis BFT-3 Inhibitors in the Animal Infection Model Galleria mellonella. [PDF]
Jiménez-Alesanco A +6 more
europepmc +1 more source

